STOCK TITAN

Teleflex™ Chooses o9’s AI-Powered Platform for End-to-End Integrated Business Planning and Supply Chain Management

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
AI

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has chosen o9's AI-powered platform to enhance its end-to-end integrated business planning and supply chain management capabilities. The partnership includes o9's Demand Planning, Supply Planning, and Integrated Business Planning (IBP) technologies.

Teleflex, headquartered in Wayne, Pennsylvania, offers a diverse portfolio of solutions in anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company aims to improve the health and quality of people's lives and become the most trusted partner in healthcare.

David Clarke, Vice President of Demand Fulfilment at Teleflex, expressed confidence in o9's ability to handle their complex supply chain requirements and help achieve strategic objectives. o9's platform is expected to enhance supply chain efficiency, optimize inventory, and empower Teleflex's workforce through improved processes and technology.

Teleflex Incorporated (NYSE: TFX), un fornitore globale leader di tecnologie mediche, ha scelto la piattaforma basata su intelligenza artificiale di o9 per migliorare le sue capacità di pianificazione aziendale integrata e gestione della catena di approvvigionamento. La partnership include le tecnologie di Pianificazione della Domanda, Pianificazione dell'Offerta e Pianificazione Aziendale Integrata (IBP) di o9.

Teleflex, con sede a Wayne, Pennsylvania, offre un portfolio diversificato di soluzioni in anestesia, medicina d'urgenza, cardiologia interventistica e radiologia, chirurgia, accesso vascolare e urologia. L'azienda mira a migliorare la salute e la qualità della vita delle persone e diventare il partner più affidabile nel settore sanitario.

David Clarke, Vice Presidente della Soddisfazione della Domanda presso Teleflex, ha espresso fiducia nella capacità di o9 di gestire i requisiti complessi della loro catena di approvvigionamento e di aiutare a raggiungere obiettivi strategici. Si prevede che la piattaforma di o9 migliori l'efficienza della catena di approvvigionamento, ottimizzi l'inventario e potenzi il personale di Teleflex attraverso processi e tecnologie migliorate.

Teleflex Incorporated (NYSE: TFX), un proveedor global líder de tecnologías médicas, ha elegido la plataforma impulsada por inteligencia artificial de o9 para mejorar sus capacidades de planificación empresarial integrada de extremo a extremo y gestión de la cadena de suministro. La asociación incluye las tecnologías de Planificación de la Demanda, Planificación de la Oferta y Planificación Empresarial Integrada (IBP) de o9.

Teleflex, con sede en Wayne, Pennsylvania, ofrece una cartera diversa de soluciones en anestesia, medicina de emergencia, cardiología intervencionista y radiología, cirugía, acceso vascular y urología. La empresa tiene como objetivo mejorar la salud y la calidad de vida de las personas y convertirse en el socio más confiable en el cuidado de la salud.

David Clarke, Vicepresidente de Cumplimiento de la Demanda en Teleflex, expresó confianza en la capacidad de o9 para manejar sus complejos requisitos de cadena de suministro y ayudar a alcanzar objetivos estratégicos. Se espera que la plataforma de o9 mejore la eficiencia de la cadena de suministro, optimice el inventario y empodere a la fuerza laboral de Teleflex a través de procesos y tecnologías mejoradas.

텔레플렉스 주식회사 (NYSE: TFX)는 의료 기술의 글로벌 선도 제공업체로, 끝에서 끝까지 통합 비즈니스 계획 및 공급망 관리 기능을 향상시키기 위해 o9의 AI 기반 플랫폼을 선택했습니다. 이 파트너십에는 o9의 수요 계획, 공급 계획 및 통합 비즈니스 계획 (IBP) 기술이 포함됩니다.

펜실베이니아주 웨인에 본사를 둔 텔레플렉스는 마취, 응급 의료, 인터벤션 심장학 및 방사선학, 외과, 혈관 접근 및 비뇨기과 분야에서 다양한 솔루션을 제공합니다. 이 회사는 사람들의 건강과 삶의 질을 개선하고 의료 분야에서 가장 신뢰받는 파트너가 되는 것을 목표로 하고 있습니다.

데이비드 클락, 텔레플렉스의 수요 충족 부사장은 o9가 그들의 복잡한 공급망 요구 사항을 처리하고 전략적 목표 달성을 돕는 능력에 대한 신뢰를 표명했습니다. o9의 플랫폼은 공급망 효율성을 향상시키고, 재고를 최적화하며, 개선된 프로세스와 기술을 통해 텔레플렉스의 인력을 강화할 것으로 예상됩니다.

Teleflex Incorporated (NYSE: TFX), un fournisseur mondial de premier plan de technologies médicales, a choisi la plateforme alimentée par l'IA de o9 pour améliorer ses capacités de planification commerciale intégrée de bout en bout et de gestion de la chaîne d'approvisionnement. Le partenariat comprend les technologies de Planification de la Demande, Planification de l'Offre et Planification Commerciale Intégrée (IBP) de o9.

Teleflex, dont le siège est situé à Wayne, en Pennsylvanie, propose un portefeuille diversifié de solutions en anesthésie, médecine d'urgence, cardiologie interventionnelle et radiologie, chirurgie, accès vasculaire et urologie. L'entreprise vise à améliorer la santé et la qualité de vie des personnes et à devenir le partenaire le plus fiable dans le domaine des soins de santé.

David Clarke, Vice-Président du Remplissage de la Demande chez Teleflex, a exprimé sa confiance dans la capacité de o9 à gérer leurs exigences complexes de chaîne d'approvisionnement et à aider à atteindre des objectifs stratégiques. La plateforme de o9 devrait améliorer l'efficacité de la chaîne d'approvisionnement, optimiser les stocks et renforcer le personnel de Teleflex grâce à des processus et des technologies améliorés.

Teleflex Incorporated (NYSE: TFX), ein führender globaler Anbieter medizinischer Technologien, hat die KI-gestützte Plattform von o9 gewählt, um seine integrierten Geschäftsplanungs- und Lieferkettenmanagement-Fähigkeiten zu verbessern. Die Partnerschaft umfasst die Nachfrageplanung, Angebotsplanung und integrierte Geschäftsplanung (IBP)-Technologien von o9.

Teleflex hat seinen Sitz in Wayne, Pennsylvania, und bietet ein vielfältiges Portfolio von Lösungen in den Bereichen Anästhesie, Notfallmedizin, interventionelle Kardiologie und Radiologie, Chirurgie, vaskulärer Zugang und Urologie. Das Unternehmen hat zum Ziel, die Gesundheit und die Lebensqualität der Menschen zu verbessern und der vertrauenswürdigste Partner im Gesundheitswesen zu werden.

David Clarke, Vice President of Demand Fulfilment bei Teleflex, äußerte Vertrauen in die Fähigkeit von o9, ihre komplexen Anforderungen an die Lieferkette zu bewältigen und strategische Ziele zu erreichen. Es wird erwartet, dass die Plattform von o9 die Effizienz der Lieferkette verbessert, den Lagerbestand optimiert und das Personal von Teleflex durch verbesserte Prozesse und Technologien stärkt.

Positive
  • Partnership with o9 to enhance end-to-end integrated business planning and supply chain management
  • Potential for improved supply chain efficiency and inventory optimization
  • Implementation of advanced AI-powered planning technologies
Negative
  • None.

Insights

Teleflex's adoption of o9's AI-powered platform marks a significant step towards enhancing their supply chain efficiency. This move is likely to streamline their end-to-end integrated business planning, potentially leading to improved inventory management and demand forecasting accuracy. For a global medical technology company like Teleflex, optimizing these aspects is important for maintaining competitive edge and ensuring product availability.

The implementation of o9's Demand Planning, Supply Planning and Integrated Business Planning technologies could result in:

  • Reduced inventory costs
  • Improved service levels
  • Enhanced capacity utilization
  • Better alignment between supply and demand

While the immediate financial impact isn't quantified, the long-term benefits could be substantial. Investors should monitor future earnings reports for improvements in operational efficiency and profit margins, which could positively influence Teleflex's stock performance.

The partnership between Teleflex and o9 Solutions highlights the growing trend of AI adoption in healthcare supply chains. o9's "Digital Brain" platform represents a cutting-edge approach to business planning and decision-making, leveraging AI to handle complex supply chain requirements.

Key technological benefits include:

  • Integration of multiple data sources for more accurate forecasting
  • Real-time adjustments to supply and demand fluctuations
  • Advanced analytics for strategic decision-making

This move positions Teleflex at the forefront of digital transformation in medical technology supply chains. It's a strategic investment that could yield significant competitive advantages in terms of operational agility and responsiveness to market changes. Investors should view this as a positive indicator of Teleflex's commitment to innovation and long-term efficiency gains.

DALLAS--(BUSINESS WIRE)-- o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has selected o9 to help enhance its end-to-end integrated business planning and supply chain management capabilities. This partnership includes o9’s Demand Planning, Supply Planning, and Integrated Business Planning (IBP) technologies.

Headquartered in Wayne, Pennsylvania, as a global provider of medical technologies, Teleflex is driven by its purpose to improve the health and quality of people’s lives. Through its vision to become the most trusted partner in healthcare, Teleflex offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. Teleflex believes that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.

“During our initial conversations, it was clear that o9 had the capabilities to handle our complex and unique supply chain requirements. We look forward to leveraging the o9 platform to enhance our supply chain efficiency, optimize inventory, and achieve our strategic objectives. We expect this partnership will help us empower our people through process and technology,” said David Clarke, Vice President, Demand Fulfilment at Teleflex.

o9 helps organizations overcome integration challenges and reduce complexities across the product and regulatory supply chain. Its proprietary platform helps companies enhance demand planning capabilities, improve forecast accuracy, optimize supply and production plans to increase capacity utilization, and improve service levels while establishing digital IBP processes across multiple business functions globally.

Chakri Gottemukkala, Co-founder and CEO of o9, said, “Our commitment to addressing complex business challenges and providing transformative solutions – while also ensuring client value – aligns with Teleflex’s goals. This partnership underscores our mission to deliver innovative planning capabilities through our state-of-the-art Digital Brain platform, enabling our clients to achieve their strategic objectives and drive sustainable growth.”

Learn more at www.o9solutions.com.

About o9

o9 is a leading AI-powered platform for integrated business planning and decision-making for the enterprise. Whether it is driving demand, aligning demand and supply, or optimizing commercial initiatives, any planning process can be made faster and smarter with o9’s AI-powered digital solutions. o9 brings together technology innovations—such as graph-based enterprise modeling, big data analytics, advanced algorithms for scenario planning, collaborative portals, easy-to-use interfaces and cloud-based delivery—into one platform. For more information, please visit www.o9solutions.com.

Evelien van der Wel

evelien.vanderwel@o9solutions.com

Source: o9

FAQ

What AI platform has Teleflex (TFX) chosen for its business planning and supply chain management?

Teleflex (TFX) has chosen o9's AI-powered platform for its end-to-end integrated business planning and supply chain management capabilities.

What specific technologies from o9 will Teleflex (TFX) be implementing?

Teleflex (TFX) will be implementing o9's Demand Planning, Supply Planning, and Integrated Business Planning (IBP) technologies.

How does Teleflex (TFX) expect to benefit from the partnership with o9?

Teleflex (TFX) expects to enhance supply chain efficiency, optimize inventory, achieve strategic objectives, and empower its workforce through improved processes and technology.

What medical technology areas does Teleflex (TFX) specialize in?

Teleflex (TFX) specializes in medical technologies for anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology.

Teleflex Incorporated

NYSE:TFX

TFX Rankings

TFX Latest News

TFX Stock Data

8.64B
46.31M
0.28%
99.65%
1.42%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
WAYNE